 "Lupin, Granules India recall 971,000 diabetes drug bottles in US market")
Drug makers Lupin and Granules India are recalling close to 971,000 bottles of generic diabetes drug in the US due to possibility of the affected lot containing cancer causing nitrosodimethylamine (NDMA) above the acceptable intake limit.
As per the latest Enforcement Report of the US Food and Drug Administration (USFDA), Lupin is recalling 492,858 bottles of Metformin Hydrochloride extended-release tablets in 500 mg and 1,000 strengths.
On the other hand, Hyderabad-based Granules India is recalling over 478,000 bottles of the drug in 750 mg strength.
As per the USFDA, the companies are recalling the product due to deviation from the
